Expressing support for the designation of July 17, 2024, as "Glioblastoma Awareness Day".
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™House Resolution 1203 from the 118th Congress is a non-binding resolution expressing support for designating July 17, 2024, as "Glioblastoma Awareness Day." The bill aims to raise public awareness about glioblastoma, a type of brain cancer. The resolution was referred to the Subcommittee on Health but ultimately failed or expired without further legislative action. The bill does not include any funding provisions or regulatory changes.
H.Res. 1203 sought to promote awareness of glioblastoma by designating a specific awareness day but did not advance beyond subcommittee referral and expired without enactment.
- The bill designates July 17, 2024, as "Glioblastoma Awareness Day."
- It is a House resolution, which is typically non-binding and symbolic.
- The resolution was referred to the Subcommittee on Health but did not progress further and expired.
['Patients and families affected by glioblastoma', 'Health advocacy groups focused on brain cancer', 'Medical research organizations interested in glioblastoma']
['No direct funding or resources are allocated, limiting practical impact.', 'As a non-binding resolution, it does not create enforceable policy changes.', "The resolution's failure to advance may reflect limited legislative prioritization."]
The resolution was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It aligns with common congressional practices of designating awareness days to highlight health issues. However, it did not receive further legislative action and expired, indicating it did not become a formal congressional expression.
No hidden impact flags detected
GovScope reviewed 0 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
GovScope did not receive a hidden-impact review for this bill.
['Raising awareness could potentially increase public interest and support for glioblastoma research and patient support services.', 'Symbolic recognition may encourage advocacy organizations to coordinate awareness campaigns around the designated date.']
The bill is a symbolic House resolution without binding authority or funding. Transparency considerations include the lack of detailed legislative text and the absence of budgetary implications. The resolution's referral and expiration status are clearly documented, providing a transparent legislative history.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.